Get started
Xtant Medical Holdings, Inc.Xtant Medical Holdings, Inc.Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

XTNT chart


Full chart

XTNT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪50.04 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.1337 USD
Net income (FY)
‪660.00 K‬ USD
Revenue (FY)
‪91.30 M‬ USD
Shares float
‪51.55 M‬
Beta (1Y)
1.69

Employees


Employees (FY)
215
Change (1Y)
+80 +59.26%
Revenue / Employee (1Y)
‪424.67 K‬ USD
Net income / Employee (1Y)
‪3.07 K‬ USD

About Xtant Medical Holdings, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Sean E. Browne
Website
xtantmedical.com
Headquarters
Belgrade
Founded
2006
FIGI
BBG000Q44D18
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

XTNT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of XTNT is 0.3954 USD — it has increased by 11.94% in the past 24 hours. Watch Xtant Medical Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Xtant Medical Holdings, Inc. stocks are traded under the ticker XTNT.
XTNT stock has risen by 10.41% compared to the previous week, the month change is a −2.82% fall, over the last year Xtant Medical Holdings, Inc. has showed a −64.70% decrease.
We've gathered analysts' opinions on Xtant Medical Holdings, Inc. future price: according to them, XTNT price has a max estimate of 3.00 USD and a min estimate of 1.50 USD. Watch XTNT chart and read a more detailed Xtant Medical Holdings, Inc. stock forecast: see what analysts think of Xtant Medical Holdings, Inc. and suggest that you do with its stocks.
XTNT reached its all-time high on Jan 3, 2011 with the price of 1,080.4320 USD, and its all-time low was 0.3310 USD and was reached on Dec 16, 2024. View more price dynamics on XTNT chart.
See other stocks reaching their highest and lowest prices.
XTNT stock is 8.51% volatile and has beta coefficient of 1.69. Track Xtant Medical Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Xtant Medical Holdings, Inc. there?
Today Xtant Medical Holdings, Inc. has the market capitalization of ‪56.02 M‬, it has decreased by −5.35% over the last week.
Yes, you can track Xtant Medical Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Xtant Medical Holdings, Inc. is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
XTNT earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.03 USD resulting in a −60.00% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about Xtant Medical Holdings, Inc. earnings.
Xtant Medical Holdings, Inc. revenue for the last quarter amounts to ‪27.94 M‬ USD, despite the estimated figure of ‪29.30 M‬ USD. In the next quarter, revenue is expected to reach ‪31.80 M‬ USD.
XTNT net income for the last quarter is ‪−5.02 M‬ USD, while the quarter before that showed ‪−3.86 M‬ USD of net income which accounts for −30.12% change. Track more Xtant Medical Holdings, Inc. financial stats to get the full picture.
No, XTNT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 215.00 employees. See our rating of the largest employees — is Xtant Medical Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Xtant Medical Holdings, Inc. EBITDA is ‪−9.91 M‬ USD, and current EBITDA margin is −7.65%. See more stats in Xtant Medical Holdings, Inc. financial statements.
Like other stocks, XTNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Xtant Medical Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Xtant Medical Holdings, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Xtant Medical Holdings, Inc. stock shows the strong sell signal. See more of Xtant Medical Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.